We are live on
!
Find out more
P3 Health Partners
PIII
PIII
Fund managers haven’t disclosed any holdings of PIII yet.
PIII Hedge Fund Activity: Q1 2026 in Review
17 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q1 2026, worth a combined $750K — down 27% from $1.03M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PIII positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Diversified Trust, opening a new position worth an estimated $53.5K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $480K sold.
- 17 institutional investors held P3 Health Partners (PIII) as of Q1 2026, up from 13 in Q4 2025.
- Funds reported $750K of P3 Health Partners stock for Q1 2026, down 27% quarter-over-quarter.
- 8 funds opened new P3 Health Partners positions in Q1 2026 and 3 closed out, a net change of +5 holders.
- The largest P3 Health Partners buyer in Q1 2026 was Diversified Trust, an estimated $53.5K added.
- The largest P3 Health Partners seller in Q1 2026 was Alyeska Investment Group, an estimated $480K sold.
Based on aggregated 13F filings for Q1 2026.